In HCC, NK cells are key players in antitumor immunity, primarily due to their capacity to recognize stress-induced ligands such as MHC class I-related chain A/B (MICA/B) and UL16-binding proteins (ULBPs) on the surface of cancer cells. This evidence concerns the gene MICA and hepatocellular carcinoma.